| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |